A carregar...
A review of omalizumab for the management of severe asthma
Despite the expansion of the understanding in asthma pathophysiology and the continual advances in disease management, a small subgroup of patients remain partially controlled or refractory to standard treatments. Upon the identification of immunoglobulin E and other inflammatory mediators, investig...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4970638/ https://ncbi.nlm.nih.gov/pubmed/27528798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S112208 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|